Preclinical and clinical research focused on Parkinson’s disease has reached a “pivotal point”, but funding barriers and outdated clinical trial approaches remain critical barriers to innovation, says ...

Up to one in three people with Parkinson’s disease use at least one psychotropic medication, a recent study from the University of Eastern Finland shows. People with Parkinson’s disease were using ...